- No file added yet -

Plasmodium proteins useful for preparing vaccine compositions

standard

posted on 2016-06-07, 00:00 authored by John H. Adams, John P. Dalton, Stefan Kappe

The present invention relates to DNA segments encoding MAEBL, an erythrocyte binding protein of a Plasmodium parasite, to substantially pure MAEBL proteins and to recombinantly or synthetically produced MAEBL molecules. The MAEBL proteins can be utilized as a vaccine for humans against malaria.

History

Patent Number

US 6120770 B2

Other Application

08/929,329

USPTO Link

http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=/netahtml/PTO/search-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN/6120770

Inventor

John H. Adams Stefan Kappe John P. Dalton

Inventor from Local Institution

John H. Adams

Assignee

University of Notre Dame Du Lac

Date Modified

2016-06-07

Language

English

Claims

6

Publisher

United States Patent and Trademark Office

Cooperative Patent Classification Codes

C07K 14/445 (20130101); A61K 39/00 (20130101)

Contributor

John H. Adams

International Patent Classification Codes

C07K 14/435 (20060101); C07K 14/445 (20060101); A61K 39/00 (20060101); A61K 039/00 (); A61K 039/002 (); A61K 039/015 (); C07K 001/00 ()

US Patent Classification Codes

24/185.1; 424/191.1; 424/268.1; 424/272.1; 530/300; 530/324; 530/325; 530/326; 530/327; 530/328; 530/329; 530/350;

Usage metrics

Keywords

Not Assigned

Licence

CC BY 4.0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC